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INVOLVEMENT OF PHOSPHOLIPIDS IN THE COUPLING
OF ADENOSINE AND DOPAMINE RECEPTORS TO RAT
STRIATAL ADENYLATE CYCLASE
MADHU B. ANAND-SRIVASTAVA AND ROGER A. JOHNSON
Department ofPhysiology, Vanderbilt University Medical School, Nashville, Tennessee 37232 U.S.A.
Phospholipids are known to play an important role in the
integrity of cell membrane and in the activity of
membrane-bound enzymes. The involvement of membrane
phospholipids in hormone-responsive adenylate cyclases in
various tissues has been studied in many laboratories
(Birnbaumer et al., 1971; Levey, 1971a and 1971b; Pohl et
al., 1971; Rubalcava and Rodbell, 1973; Lad et al., 1979).
The presence of adenosine and dopamine-sensitive
cyclases in rat brain striatum has been reported earlier
(Clement-Cormier et al., 1975; Premont et al., 1977;
Anand-Srivastava and Johnson, 1980). It has also been
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FIGURE 1 Effect of phospholipase A2 treatment on adenylate cyclase
activity of striatal washed particles. Activity was measured in the absence
(0-@) and presence (-O-) of 100 MM PIA, 100 MM dopamine (-A-), and
10 mM-NaF (-A-). The phospholipase A2 treatment was performed at
200C for 10 min. Adenylate cyclase activity was measured in the
presence of 10 MM-GTP. Values are the averages of two experiments,
each run in triplicate.
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reported that adenosine and dopamine stimulate adenylate
cyclase by different mechanisms (Anand-Srivastava and
Johnson, 1980). The present report explores phospholipid
requirements for the regulation of adenylate cyclase by
adenosine and dopamine and approaches the question of
possible differences in modes of coupling of adenosine and
dopamine receptors to the cyclase.
RESULTS AND DISCUSSION
Striatal washed particles were prepared by the method
described previously (Anand-Srivastava and Johnson,
1980). Adenylate cyclase activity was determined by
measuring [32P]cAMP formation from [a32P] ATP by a
modification (Walseth and Johnson, 1979) of the method
described by Jakobs et al., (1976).
Fig. 1 shows the differential effects of phospholipase A2
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FIGURE 2 Effect of various concentrations of Lubrol-PX on striatal
adenylate cyclase activity. Washed particles were incubated with various
concentrations of Lubrol-PX at 20°C for 10 min. Particles were diluted to
give a final concentration of 1.2 mg protein/ml to maintain constant
protein:detergent ratios between experiments. Adenylate cyclase activity
was measured in the presence of 100MM PIA (4-) or 100MM dopamine
(0-O). Values are means ± SEM of four different experiments, each run
in triplicate.
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TABLE I
EFFECT OF ASOLECTIN ON ADENYLATE CYCLASE
ACTIVITIES. FROM LUBROL-PX-TREATED WASHED
PARTICLES
Adenylate cyclase activity
Treatment PIA Dopamine
Basal 100 AM 100 gM
pmol cAMP (5 min mg protein) - 1
Control 163 ± 2 388 ± 5 314 ± 11
Control + asolectin (1%) 203 ± 1 463 ± 8 380 ± 10
16,000 g supernatant
fraction 50 ± 1 78 ± 4 50 ± 4
16,000 g supernatant
fraction + asolectin 83 ± 4 171 ± 3 73 ± 3
BioBead SM-2 fraction* 93 ± 13 207 ± 3 122 ± 4
BioBead SM-2 Fraction +
asolectin (1%) 173 ± 5 465 ± 1 192 ± 22
Washed particles were treated with (0.03%) Lubrol-PX for 10 min at 200
and then were centrifuged at 16,000 g for 10 min. 16,000 g supernatant
fraction was assayed for activity. All fractions were further incubated at
200 without and with 1% asolectin for 20 min and were used for adenylate
cyclase assay. Values represent means ± SEM of triplicate determina-
tions from one of two experiments.
* 1 ml of the 16,000 g supernatant fraction was passed over BioBead SM
2 column (2 x 0.7 cm equilibrated and run with 10mM imidazole, 1 mM
EDTA buffer, pH 7.5) and assayed for cyclase activity.
treatment on adenosine and dopamine-sensitive cyclases.
Phospholipase A2 at a concentration of 1 U/ml completely
abolished dopamine-sensitive cyclase activity without
affecting N6-phenylisopropyladenosine (PIA) sensitivity.
The inactivation of dopamine-sensitive activity was
reversed by subsequent treatment with asolectin or phos-
phalidylcholine, phosphatidylserine, or phosphatidyletha-
nolamine (data not shown). Thus the data suggest that
phospholipid plays an important role in the coupling
process for dopamine activation of the cyclase, and that
either the adenosine receptor or its coupling process does
not require phospholipid or that the phospholipids involved
in the coupling process are not affected by the treatments
we used.
The conclusion from studies with the phospholipases
are supported further by observations made with Lubrol-
PX. Lubrol-PX completely abolished dopamine sensitivity
under conditions causing only slight inhibition of sensitiv-
ity to PIA (Fig. 2). Moreover, Lubrol-PX extracted a
PIA-sensitive but not dopamine-sensitive cyclase into a
16,000 g supernatant fraction (Table T). This was more
evident once most of the free detergent was removed from
this fraction by treatment with SM-2 Biobeads and by the
addition of asolectin. The asolectin reversed any effect that
Lubrol-PX may have had on PIA-sensitive adenylate
cyclase but did not restore dopamine sensitivity. The
dopamine receptor or the coupling process may have been
irreversibly destroyed or separated from the cyclase under
these conditions, whereas the coupling of the adenosine
receptor remained largely intact.
Thus, adenosine receptors may be viewed as being more
tightly coupled to the cyclase than are dopamine receptors
and are thereby much less susceptible to modifications of
the lipid environment of the membrane by phospholipases
or detergents. Alternatively, the coupling process for
dopamine and adenosine receptors and adenylate cyclase
may occur by different mechanisms and involve different
membrane constituents.
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